Cargando…

Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]

Detalles Bibliográficos
Autores principales: Bancroft, Elizabeth K., Eeles, Rosalind A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597558/
https://www.ncbi.nlm.nih.gov/pubmed/25944041
http://dx.doi.org/10.1016/j.eururo.2014.12.001
_version_ 1783263723537825792
author Bancroft, Elizabeth K.
Eeles, Rosalind A.
author_facet Bancroft, Elizabeth K.
Eeles, Rosalind A.
author_sort Bancroft, Elizabeth K.
collection PubMed
description
format Online
Article
Text
id pubmed-5597558
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-55975582018-04-17 Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99] Bancroft, Elizabeth K. Eeles, Rosalind A. Eur Urol Article Elsevier Science 2015-06 /pmc/articles/PMC5597558/ /pubmed/25944041 http://dx.doi.org/10.1016/j.eururo.2014.12.001 Text en © 2014 Elsevier B.V. on behalf of European Association of Urology. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Bancroft, Elizabeth K.
Eeles, Rosalind A.
Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]
title Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]
title_full Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]
title_fullStr Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]
title_full_unstemmed Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]
title_short Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]
title_sort corrigendum to “targeted prostate cancer screening in brca1 and brca2 mutation carriers: results from the initial screening round of the impact study” [eur urol 2014;66:489–99]
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597558/
https://www.ncbi.nlm.nih.gov/pubmed/25944041
http://dx.doi.org/10.1016/j.eururo.2014.12.001
work_keys_str_mv AT bancroftelizabethk corrigendumtotargetedprostatecancerscreeninginbrca1andbrca2mutationcarriersresultsfromtheinitialscreeningroundoftheimpactstudyeururol20146648999
AT eelesrosalinda corrigendumtotargetedprostatecancerscreeninginbrca1andbrca2mutationcarriersresultsfromtheinitialscreeningroundoftheimpactstudyeururol20146648999
AT corrigendumtotargetedprostatecancerscreeninginbrca1andbrca2mutationcarriersresultsfromtheinitialscreeningroundoftheimpactstudyeururol20146648999